21 – 30 of 92
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
The role of extracellular vesicle fusion with target cells in triggering systemic inflammation
- Contribution to journal › Article
-
Mark
An integrated omics approach highlights how epigenetic events can explain and predict response to neoadjuvant chemotherapy and bevacizumab in breast cancer
- Contribution to journal › Article
-
Mark
Kataegis in clinical and molecular subgroups of primary breast cancer
(2024) European Association for Cancer Research
- Contribution to conference › Poster
-
Mark
Tumor purity estimated from bulk DNA methylation can be used for adjusting beta values of individual samples to better reflect tumor biology
- Contribution to journal › Article
-
Mark
A Versatile and Upgraded Version of the LundTax Classification Algorithm Applied to Independent Cohorts
- Contribution to journal › Article
-
Mark
Longitudinal molecular profiling elucidates immunometabolism dynamics in breast cancer
- Contribution to journal › Article
- 2023
-
Mark
CD169+ Macrophages in Primary Breast Tumors Associate with Tertiary Lymphoid Structures, Tregs and a Worse Prognosis for Patients with Advanced Breast Cancer
- Contribution to journal › Article
-
Mark
Breast cancer associated CD169+ macrophages possess broad immunosuppressive functions but enhance antibody secretion by activated B cells
- Contribution to journal › Article
-
Mark
Combining histological grade, TILs, and the PD-1/PD-L1 pathway to identify immunogenic tumors and de-escalate radiotherapy in early breast cancer : A secondary analysis of a randomized clinical trial
- Contribution to journal › Article
-
Mark
A deep tabular data learning model predicting cisplatin sensitivity identifies BCL2L1 dependency in cancer
- Contribution to journal › Article
